对于双重血清阴性神经omyelitis光学谱疾病的Rituximab疗法
Jose Carlos D Saballegue1, Ma Luisa Gwenn P Tiongson2
1Center for Neurological Sciences, Quirino Memorial Medical Center, Quezon City, PHL.
Cureus
|June 10, 2024
概括
这项案例研究突出显示,瑞思基马布作为双阴性神经炎光学谱障碍 (NMOSD) 的有效治疗方法,改善了患者的治疗结果并降低了复发风险.
科学领域:
- 神经免疫学 神经免疫学
- 神经学 神经学
- 临床案例研究 临床案例研究
背景情况:
- 神经脊髓炎光谱障碍 (NMOSD) 是一种罕见的中枢神经系统炎症性疾病.
- NMOSD可以对水-4或抗转基因抗体呈血清阳性,也可以是血清阴性.
- 双阳性NMOSD带来了诊断和治疗方面的挑战.
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
01:15Myasthenia Gravis: Diagnostic Tests
767
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
767